Bone marrow-derived mononuclear cells promote improvement in glomerular function in rats with early diabetic nephropathy

Cellular Physiology and Biochemistry

Volumn 32, Issue 3, 2013, Pages 699-718

  Castiglione, Raquel C ^a   Maron Gutierrez, Tatiana ^a   Barbosa, Carolina M L ^a   Ornellas, Felipe M ^a   Barreira, André Luis ^a   Dibarros, Carolina B A ^a   Vasconcelos Dos Santos, Andréia ^a   Paredes, Bruno Diaz ^a   Pascarelli, Bernardo M ^b   Diaz, Bruno L ^a   Rossi Bergmann, Bartira ^a   Takiya, Christina M ^a   Rocco, Patricia R M ^a   Souza Menezes, Jackson ^a   Morales, Marcelo M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bone marrow mononuclear cells; Cytokines; Diabetic nephropathy; Renal function

Indexed keywords

ARGINASE 1; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CHLORIDE; CREATININE; ED1 PROTEIN; GLUCOSE; GLYCOPROTEIN; NESTIN; POTASSIUM; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL THERAPY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ELECTROLYTE EXCRETION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; MACROPHAGE; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; BONE MARROW DERIVED MONONUCLEAR CELL; CHLORIDE URINE LEVEL; COLLAGEN FIBER; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MORPHOMETRICS; POTASSIUM URINE LEVEL; SODIUM URINE LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ARGINASE; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW CELLS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ECTODYSPLASINS; GLOMERULAR FILTRATION RATE; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; PROTEINURIA; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884993377     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354473     Document Type: Article

References (73)

1. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15: 539-553.
2. Schrijvers BF, de Vriese AS, Flyvbjerg A: From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004;25: 971-1010.
3. Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyo JM: Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004;53: 1119-1127.
4. Ellis EN, Warady BA, Wood EG, Hassanein R, Richardson WP, Lane PH, Howard C, Kemp SF, Aceto T, Garibaldi L, Wiegmann TB, Savin VJ: Renal structural-functional relationships in early diabetes mellitus. Pediatr Nephrol 1997;11: 584-591.
5. Kim HJ, Kong MK, Kim YC: Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin-induced diabetic rats. BMB Rep 2008;41: 710-715.
6. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM: Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 2005;48: 2650-2660.
7. Dronavalli S, Duka I, Bakris GL: The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008;4: 444-452.
8. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28: 164-176.
9. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74: 1143-1155.
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414: 813-820.
11. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004;65: 116-128.
12. Ichinose K, Kawasaki E, Eguchi K: Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 2007;27: 554-564.
13. Hill C, Flyvbjerg A, Rasch R, Bak M, Logan A: Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 2001;170: 647-651.
14. Dixon A, Maric C: 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol 2007;293:F1678-1690.
15. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 1998;54: 1872-1878.
16. Ziyadeh FN: Mediators of diabetic renal disease: the case for TGF- as the major mediator. J Am Soc Nephrol 2004;15: 55S-57S.
17. Thorp ML: Diabetic nephropathy: common questions. Am Fam Physician 2005;72: 96-99.
18. Barreira AL, Takiya CM, Castiglione RC, Maron-Gutierrez T, Barbosa CM, Ornellas DS, Verdoorn KS, Pascarelli BM, Borojevic R, Einicker-Lamas M, Leite M Jr, Morales MM, Vieyra A: Bone marrow mononuclear cells attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells after unilateral ureteral obstruction. Cell Physiol Biochem 2009;24: 585-594.
19. Caldas HC, Fernandes IM, Gerbi F, Souza AC, Baptista MA, Ramalho HJ, Kawasakioyama RS, Goloni-Bertollo EM, Pavarino-Bertelli EC, Braile DM, Abbud-Filho M: Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 2008;40: 853-855.
20. Carvalho S, Cortez E, Stumbo AC, Thole A, Caetano C, Marques R, Pelajo-Machado M, Porto LC, Carvalho L: Laminin expression during bone marrow mononuclear cell transplantation in hepatectomized rats. Cell Biol Int 2008;32: 1014-1018.
21. Crovace A, Lacitignola L, Francioso E, Rossi G: Histology and immunohistochemistry study of ovine tendon grafted with cBMSCs and BMMNCs after collagenase-induced tendinitis. Vet Comp Orthop Traumatol 2008;21: 329-336.
22. Goel RK, Suri V, Suri A, Sarkar C, Mohanty S, Sharma MC, Yadav PK, Srivastava A: Effect of bone marrow-derived mononuclear cells on nerve regeneration in the transection model of the rat sciatic nerve. J Clin Neurosci 2009;16: 1211-1217.
23. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106: 1913-1918.
24. Yoo KJ, Kim HO, Kwak YL, Kang SM, Jang YS, Lim SH, Hwang KC, Cho SW, Yang YS, Li RK, Kim BS: Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy. Can J Surg 2008;51: 269-275.
25. Dolber PC, Spach MS: Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 1993;41: 465-469.
26. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity 2010;32: 593-604.
27. Guerrero AR, Uchida K, Nakajima H, Watanabe S, Nakamura M, Johnson WE, Baba H: Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 2012;9: 40.
28. Redente EF, Orlicky DJ, Bouchard RJ, Malkinson AM : Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am J Pathol 2007;170: 693-708.
29. Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H: The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats. Kidney Int 2004;65: 540-550.
30. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO: Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003;46: 1153-1160.
31. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjoquist M: C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005;20: 532-538.
32. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ: Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006;103: 17438-17443.
33. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA: Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008;14: 631-640.
34. Ezquer F, Ezquer M, Simon V, Pardo F, Yañez A, Carpio D, Conget P: Endovenous administration of bone marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol Blood Marrow Transplant 2009;15: 1354-1365.
35. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999;56: 1627-1637.
36. Tang SC, Leung JC, Lai KN: Diabetic tubulopathy: an emerging entity. Contrib Nephrol 2011;170: 124-134.
37. Tang SCW, Chan LYY, Leung JCK, Cheng AS, Chan KW, Lan HY, Lai KN: Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant 2009;25: 698-710.
38. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996;45: 522-530.
39. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995;44: 1139-1146.
40. Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005;54: 1626-1634.
41. Suzawa H, Kikuchi S, Ichikawa K, Koda A: Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 1992;60: 85-90.
42. Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T: Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression. J Pharmacol Exp Ther 2005;314: 514-521.
43. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endthelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001;12: 993-1000.
44. Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 2004;53: 2939-2949.
45. Choudhary N, Ahlawat RS: Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria. Iran J Kidney Dis 2008;2: 72-79.
46. Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J: Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011;7: 327-340.
47. Balakumar P; Reddy J; Singh M: Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy? Mol Cell Biochem 2009;330: 187-192.
48. Galkina E, Ley K: Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 2006;17: 368-377.
49. Hartner A, Veelken R, Wittmann M, Cordasic N, Hilgers KF: Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrol 2005;6: 6.
50. Lim AKH, Ma FY, Nikolic-Paterson DJ, Thomas MC, Hurst LA, Tesch GH: Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia 2009;52: 1669-1679.
51. Tuttle KR: Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol 2005;16: 1537-1538.
52. Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H: Macrophage scavenger receptor-A-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes 2007;56: 363-372.
53. Mensah-Brown EPK, Obineche EN, Galadari S, Chandranath E, Shahin A, Ahmed I, Patel SM, Adem A: Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine 2005;31: 180-190.
54. Sassy-Prigent C, Heudes D, Mandet C, Bélair MF, Michel O, Perdereau B, Bariéty J, Bruneval P: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000;49: 466-475.
55. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transpl 2004;19: 2987-2996.
56. Berbaum K, Shanmugam K, Stuchbury G, Wiede F, Körner H, Münch G: Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine 2008;41: 198-203.
57. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25: 677-686.
58. Tesch GH: Macrophages and diabetic nephropathy. Semin Nephrol 2010;30: 290-301.
59. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993;21: 480-485.
60. Mantovani A, Sica A, Locati M: New vistas on macrophage differentiation and activation. Eur J Immunol 2007;37: 14-16.
61. Biswas SK, Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11: 889-896.
62. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM: Macrophages in tumor microenvironments and the progression of tumors [published online ahead of print Jun 19 2012]. Clin Dev Immunol 2012;2012: 948098.
63. Ma LJ, Corsa BA, Zhou J, Yang H, Li H, Tang YW, Babaev VR, Major AS, Linton MF, Fazio S, Hunley TE, Kon V, Fogo AB: Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol 2011;300:F1203-1213.
64. Fujita E, Shimizu A, Masuda Y, Kuwahara N, Arai T, Nagasaka S, Aki K, Mii A, Natori Y, Iino Y, Katayama Y, Fukuda Y: Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol 2010;177: 1143-1154.
65. Mills CD: M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 2012;32: 463-488.
66. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11: 723-737.
67. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris DC: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007;72: 290-299.
68. Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, Ramalingam TR, Thompson RW, Kamanaka M, Flavell RA, Keane-Myers A, Cheever AW, Wynn TA: IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 2007;117: 2941-2951.
69. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA: Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009;5:e1000371.
70. Sinuani I, Averbukh Z, Gitelman I, Rapoport MJ, Sandbank J, Albeck M, Sredni B, Weissgarten J: Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process. Am J Physiol Renal Physiol 2006;291:F384-394.
71. Wang Y, Tay YC, Harris DC: Proximal tubule cells stimulated by lipopolysaccharide inhibit macrophage activation. Kidney Int 2004;66: 655-662.
72. Nakajima H, Uchida K, Rodriguez Guerrero A, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright K, Johnson E, Baba H: Transplantation of mesenchymal stem cells promotes the alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 2012;29: 1614-1625.
73. Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, Davies JE, Keating A: Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophagesafter acute myocardial infarction. Basic Res Cardiol 2011;106: 1299-1310.